Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta|June 14, 2015
TRIM29 regulates the p63-mediated pathway in cervical cancer cellsYasushi Masuda, Hidehisa Takahashi, Shigetsugu Hatakeyama
International Journal of Molecular Medicine|January 5, 2006
Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cellsHiroshige Hibasami, Hirosi Iwase, Kazumi Yoshioka, et al.
International Journal of Molecular Medicine|July 14, 2005
Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cellsHiroshige Hibasami, Hiroshi Iwase, Kazumi Yoshioka, et al.
Journal of General and Family Medicine|November 10, 2021
Wellens syndrome in a young woman with coronary artery vasculitisRyohei Ono, Hidehisa Takahashi, Yasuhiko Hori, et al.
The Journal of Biological Chemistry|December 1, 2004
Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia proteinHidehisa Takahashi, Shigetsugu Hatakeyama, Hisato Saitoh, et al.
Cureus|May 11, 2023
Cardiac Arrest Due to Brugada Syndrome Associated With Influenza Infection: A Case Report and Literature ReviewRyohei Ono, Yasuhiko Hori, Tatsuro Yamazaki, et al.
Biochimica Et Biophysica Acta|June 9, 2016
p53 represses the transcription of snRNA genes by preventing the formation of little elongation complexDelnur Anwar, Hidehisa Takahashi, Masashi Watanabe, et al.
Drugs in R&D|September 14, 2022
Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial FibrillationRyohei Ono, Kazutaka Nishimura, Hidehisa Takahashi, et al.
Journal of Cardiology Cases|November 2, 2020
A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variantRyohei Ono, Hidehisa Takahashi, Tetta Sato, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 3, 2022
Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitorsRyohei Ono, Kazutaka Nishimura, Hidehisa Takahashi, et al.
Pageof 7